About Us

Mission

Accelerate the transition to rational, computerized drug discovery via simulations and machine learning.

Vision

We work with our customers by becoming a key technology partner, boosting their discovery workflow with the most innovative solutions.

Values

Science, research, innovation and development.

Background

Acellera is devoted to bring state-of-the-art technologies to drug discovery. Founded in 2006, we were one of the first companies worldwide to leverage the use of novel accelerator processor technology (GPU) applied to molecular dynamics. We developed the first online platform for drug design based on deep learning and are now leading the introduction of machine learning techniques into the drug discovery pipeline.

Today, our software ACEMD has over 700 citations, and KDeep and Deepsite are among the most cited papers in the field of ML applied to drug discovery.

Papers citing Acellera’s founders

0

Papers citing ACEMD software

0

Years of experience

0

Careers at Acellera

Open/Spontaneous application

OPEN. Didn't find an opening that fits your profile? We are always looking for great talent to join our team. For more information click here .

alejandroAbout Us